0 items USD 0.00Search
- Did you mean
- rejuvenation idiopathic arthrex
Your search for "Juvenile%20idiopathic%20arthritis" gave back 3480 results.
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 Summary According to the recently published report...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
T Lymphocyte Activation Antigen CD86 (Activation B7-2 Antigen or CTLA 4 Counter Receptor B7.2 or CD86) - Pipeline Review, H1 2018 Summary T...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Tyrosine Protein Kinase JAK2 - Pipeline Review, H2 2020 Summary According to the recently published report 'Tyrosine Protein Kinase JAK2 -...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
T Lymphocyte Activation Antigen CD80 - Pipeline Review, H2 2019 Summary T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK2 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
